Jul 27, 2015 4:01 pm EDT CymaBay Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares
Jul 15, 2015 9:10 am EDT CymaBay Therapeutics Announces Pricing of $20 Million Public Offering of Common Stock
Jul 06, 2015 8:00 am EDT CymaBay Therapeutics to Present at the Cantor Fitzgerald Inaugural Healthcare Conference
May 01, 2015 8:00 am EDT CymaBay to Announce First Quarter 2015 Financial Results on Thursday, May 7, 2015
Apr 23, 2015 8:00 am EDT CymaBay Therapeutics Announces the Initiation of a Phase 2 Study of MBX-8025 in Patients With Homozygous Familial Hypercholesterolemia